COVID-19 susceptibility and severity for dyslipidemia: A mendelian randomization investigation

BACKGROUND: The severe acute respiratory syndrome coronavirus in 2019 (COVID-19) is still spreading and causing deaths worldwide, which further increased the burden of chronic diseases. Dyslipidemia is a common metabolic syndrome, which is a major risk factor for cardiovascular disease. However, stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yi, Liu, Liang, Liang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560011/
https://www.ncbi.nlm.nih.gov/pubmed/37809746
http://dx.doi.org/10.1016/j.heliyon.2023.e20247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560011/
https://www.ncbi.nlm.nih.gov/pubmed/37809746
http://dx.doi.org/10.1016/j.heliyon.2023.e20247

Ejemplares similares